Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Slovenia

Slovenia

The COVID-19 Vaccines market in Slovenia is expected to witness significant growth in the coming years.
By 2024, revenue in this market is projected to reach US$34.06m.
Moreover, it is anticipated that the market will continue to expand at an annual growth rate of -17.85% from 2024 to 2029, resulting in a market volume of US$12.74m by 2029.
In terms of global comparison, United States is expected to generate the highest revenue in the COVID-19 Vaccines market.
In 2024, the revenue is estimated to reach a staggering US$4,389,000.00k.
Slovenia has successfully implemented a comprehensive vaccination strategy, leading to a high vaccination rate among its population.

Key regions: United Kingdom, Germany, France, South Korea, Italy

Market

Region

Region comparison

Currency

Analyst Opinion

Slovenia, a small central European country, has been making significant progress in the COVID-19 vaccination campaign. As of August 2021, over 40% of the population has been fully vaccinated. The COVID-19 Vaccines market in Slovenia has been developing in response to the increasing demand for vaccines and the government's efforts to ensure a smooth vaccination campaign.

Customer preferences: Slovenian customers have shown a high level of interest in getting vaccinated against COVID-19. The government has made vaccination easily accessible to all citizens, with vaccination centers set up across the country. The majority of the population has shown a willingness to get vaccinated, with a high level of trust in the safety and efficacy of the vaccines.

Trends in the market: The COVID-19 Vaccines market in Slovenia has seen a surge in demand for vaccines in recent months. The government has been actively procuring vaccines from various manufacturers, including Pfizer-BioNTech, Moderna, and AstraZeneca. The demand for vaccines has been driven by the government's vaccination campaign, which has prioritized the most vulnerable groups, such as the elderly and healthcare workers. The government has also made efforts to increase vaccine uptake among younger age groups by launching a social media campaign and organizing vaccination events in popular tourist destinations.

Local special circumstances: Slovenia's small size and well-developed healthcare system have allowed for a smooth rollout of the vaccination campaign. The government's proactive approach to vaccine procurement and distribution has also contributed to the success of the campaign. Additionally, the country's high level of trust in the healthcare system and government has helped to increase vaccine uptake.

Underlying macroeconomic factors: Slovenia's strong economy and high level of development have allowed for a quick and effective response to the COVID-19 pandemic. The government's significant investment in the healthcare system has also contributed to the success of the vaccination campaign. The country's membership in the European Union has also provided access to a wide range of vaccines and resources to support the vaccination campaign. Overall, the COVID-19 Vaccines market in Slovenia is expected to continue developing in response to the increasing demand for vaccines and the government's efforts to ensure a smooth vaccination campaign.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.